Cargando…

Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma

Melanoma is characterized by oncogenic mutations in pathways regulating cell growth, proliferation, and metabolism. Greater than 80% of primary melanoma cases harbor aberrant activation of the mitogen-activated protein kinase kinase/extracellular-signal-regulated kinase (MEK/ERK) pathway, with oncog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolfe, Zachary, Friedland, Julie C., Ginn, Sarah, Blackham, Aaron, Demberger, Lauren, Horton, Morgan, McIntosh, Alyson, Sheikh, Hina, Box, Jessica, Knoerzer, Deborah, Federowicz, Bryan, Stuhlmiller, Timothy J., Shapiro, Mark, Nair, Suresh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Short Communications: Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245552/ https://www.ncbi.nlm.nih.gov/pubmed/35551160 http://dx.doi.org/10.1097/CMR.0000000000000830

Ejemplares similares

Durable Complete Remission With Combination of Stereotactic Body Radiation Therapy (SBRT) and Talimogene Laherparepvec (TVEC) Followed by Ipilimumab in Refractory Metastatic Melanoma
por: Wolfe, Zachary, et al.
Publicado: (2022)

ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo
por: Yu, Yang, et al.
Publicado: (2022)

Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma
por: Grierson, Patrick M, et al.
Publicado: (2022)

Mutations in BRAF codons 594 and 596 predict good prognosis in melanoma
por: Wu, Xiaowen, et al.
Publicado: (2017)

Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignancies
por: Mendzelevski, Boaz, et al.
Publicado: (2018)

LGG-25. The first-in-class ERK inhibitor ulixertinib (BVD-523) shows activity in MAPK-driven pediatric low-grade glioma models as single agent and in combination with MEK inhibitors or senolytics
por: Sigaud, Romain, et al.
Publicado: (2022)

The development of an effective synthetic route of lesinurad (RDEA594)
por: Meng, Qing, et al.
Publicado: (2017)

594 Life-Threatening Angioedema without Urticaria (Ae-U)
por: Corey, Jacquelynne, et al.
Publicado: (2012)

SUN-594 Pubertal Timing and Hormonal Correlates in Male Obesity
por: De Schepper, Jean, et al.
Publicado: (2020)

BRAF D594A mutation defines a unique biological and immuno-modulatory subgroup associated with functional CD8(+) T cell infiltration in colorectal cancer
por: Li, Wenjing, et al.
Publicado: (2023)

The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594)
por: Breitbach, Caroline J, et al.
Publicado: (2015)

SAT-594 A Metabolic Muddle : Thyrotoxicosis Causing Diabetic Ketoacidosis
por: Dhillon, Puneet, et al.
Publicado: (2019)

Isolation of vaccinia JX594 from pustules following therapy for hepatocellular carcinoma
por: Kung, Che-Hsuan, et al.
Publicado: (2015)

PT594. Placebo effects in Alzheimer Disease: analysis of the CATIE-AD data
por: Ozawa, Chisa, et al.
Publicado: (2016)

Activation of the MKK/ERK Pathway during Somatic Cell Mitosis: Direct Interactions of Active ERK with Kinetochores and Regulation of the Mitotic 3F3/2 Phosphoantigen
por: Shapiro, Paul S., et al.
Publicado: (1998)

Case report: Complete response of an anaplastic thyroid carcinoma patient with NRAS Q61R/BRAF D594N mutations to the triplet of dabrafenib, trametinib and PD-1 antibody
por: Gui, Lin, et al.
Publicado: (2023)

Adaptative Potential of the Lactococcus Lactis IL594 Strain Encoded in Its 7 Plasmids
por: Górecki, Roman K., et al.
Publicado: (2011)

MON-594 The Peculiarity of the Gut Microbiota in Patients with Different Phenotypes of Obesity (Pilot Study)
por: Volkova, Natalia, et al.
Publicado: (2020)

594. Micafungin Prophylaxis in Acute Myeloid Leukemia Adult Patients Undergoing Induction Chemotherapy
por: Ross, Justine Abella, et al.
Publicado: (2021)

ERK5 is activated by oncogenic BRAF and promotes melanoma growth
por: Tusa, Ignazia, et al.
Publicado: (2018)

Abl Kinase Regulation by BRAF/ERK and Cooperation with Akt in Melanoma
por: Jain, Aditi, et al.
Publicado: (2017)

Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in BRAF and p.R461* in NF1 Genes—A Case Report with Literature Review
por: Grenda, Anna, et al.
Publicado: (2023)

miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2
por: Liu, Szu-Mam, et al.
Publicado: (2014)

Fibroblast Growth Factor Receptor 3 Amplified Metastatic Melanoma Treated With Erdafitinib
por: Sarkisian, Saro, et al.
Publicado: (2020)

Control of Bacterial Phenotype and Chromosomal Gene Expression by Single Plasmids of Lactococcus lactis IL594
por: Kosiorek, Katarzyna, et al.
Publicado: (2023)

Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer
por: Zaballos, Miguel A., et al.
Publicado: (2022)

Evaluating the Clinical Relevance of Codon 594 (G>A) Polymorphism of Estrogen Receptor Alpha in Knee Osteoarthritis
por: Tawonsawatruk, T, et al.
Publicado: (2014)

Targeted fetal cell‐free DNA screening for aneuploidies in 4,594 pregnancies: Single center study
por: Koc, Altug, et al.
Publicado: (2019)

The value of total thyroidectomy as the definitive treatment for Graves’ disease: A single centre experience of 594 cases
por: Cipolla, Calogero, et al.
Publicado: (2019)

Polystyrene Degradation by Exiguobacterium sp. RIT 594: Preliminary Evidence for a Pathway Containing an Atypical Oxygenase
por: Parthasarathy, Anutthaman, et al.
Publicado: (2022)

The Presence of Plasmids in Lactococcus lactis IL594 Determines Changes in the Host Phenotype and Expression of Chromosomal Genes
por: Kosiorek, Katarzyna, et al.
Publicado: (2023)

Inflammatory reaction to suture materials after flexor tendon repair. A retrospective study of 594 patients
por: Arner, Marianne, et al.
Publicado: (2023)

FRI594 Results Of A New Transition Of Care Process From Pediatric To Adult Diabetes Services
por: Cooper, Felicia Ilyssa, et al.
Publicado: (2023)

SAT594 Thyroid Dysfunction Is Very Common In Patients With Pheochromocytoma And Paraganglioma: A Cross-sectional Study
por: Ramirez-Renteria, Claudia, et al.
Publicado: (2023)

Efficacy and Safety/Toxicity Study of Recombinant Vaccinia Virus JX-594 in Two Immunocompetent Animal Models of Glioma
por: Lun, XueQing, et al.
Publicado: (2010)

Alteration of AMPA Receptor-Mediated Synaptic Transmission by Alexa Fluor 488 and 594 in Cerebellar Stellate Cells123
por: Maroteaux, Matthieu, et al.
Publicado: (2016)

594 Dermal Matrix versus Autologous Grafting for Full-Thickness Burns of Head and Neck: Trends, Outcomes, Cost
por: Di Chiaro, Bianca A, et al.
Publicado: (2022)

Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation
por: Lochhead, Pamela A., et al.
Publicado: (2016)

RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF
por: Poulikakos, Poulikos I., et al.
Publicado: (2010)

BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanoma
por: Liu, Fen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t751ldi1djojuqkv61c3qvph7k